search
Back to results

Whole Soy Replacement Diet on Metabolic Features

Primary Purpose

Metabolic Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Whole soy replacement diet
usual diet
Sponsored by
Chinese University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Metabolic Syndrome

Eligibility Criteria

45 Years - 70 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Postmenopausal women aged 45~70y within 15 years after menopause;
  2. Participants who meet 2 or more of the following items:

    • waist circumference WC ≥80 cm;
    • triglyceride concentration ≥1.7 mmol/l;
    • HDL-c <50 mg/dl (1.29 mmol/l);
    • SBP/DBP ≥130/85 mm Hg;
    • fasting glucose ≥5.6 mmol/l.

Exclusion Criteria:

  1. On use of medications known to affect body weight, lipids and glucose within past 3-month;
  2. Medical history or presence of severe systemic or endocrine diseases;
  3. Present or history of breast, endometrial or ovarian cancer;
  4. Abnormal uterine bleeding after menopause;
  5. On prescribed or vegetarian diet;
  6. Known soy allergy.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Whole soy group

    Control group

    Arm Description

    Whole soy replacement diet: to incorporate 4 servings of whole soy foods (equivalent to 25g soy protein) into their daily diet and reduce high saturated fat and cholesterol rich animal foods.

    Usual diet: to receive a conventional lifestyle education on MetS.

    Outcomes

    Primary Outcome Measures

    Changes of metabolic components of MetS (body weight, waist circumference, blood pressure, serum lipids and fasting glucose).

    Secondary Outcome Measures

    Changes of 10-year risk for ischemic cardiovascular disease (ICVD)

    Full Information

    First Posted
    November 18, 2015
    Last Updated
    November 19, 2015
    Sponsor
    Chinese University of Hong Kong
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02610322
    Brief Title
    Whole Soy Replacement Diet on Metabolic Features
    Official Title
    A Randomized Controlled Trial of Whole Soy Diet in Place of Red/Processed Meat and High Fat Dairy Products on Metabolic Features in Postmenopausal Women
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2015
    Overall Recruitment Status
    Unknown status
    Study Start Date
    June 2016 (undefined)
    Primary Completion Date
    December 2017 (Anticipated)
    Study Completion Date
    December 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Chinese University of Hong Kong

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Project title: A randomized controlled trial of whole soy diet in place of red/processed meat and high fat dairy products on metabolic features in postmenopausal women Objectives: Metabolic syndrome (MetS) is an escalating public health problem especially in postmenopausal women. Traditional whole soy foods are rich in unsaturated fats, high quality plant protein and various bioactive phytochemicals that could benefit on MetS. The aim of the study is to examine the effect of whole soy replacement diet on the features of MetS among postmenopausal women. Hypothesis to be tested: Whole soy diet in place of red or processed meat and high fat dairy products will significantly improve metabolic features. Design and subjects: This will be a 12-month randomized, single-blind, controlled trial among 208 postmenopausal women with high risk of MetS or early MetS. Study instruments: After 4 weeks' run-in, participants will be randomly allocated to either of two intervention groups, whole soy replacement group or control group, each for 6 months. Interventions: Subjects in whole soy group will be required to include 4 servings of whole soy foods (containing 25g soy protein) into their daily diet isocalorically replacing red or processed meat and high fat dairy products. Subjects in the control group will remain an usual diet. Main outcome measures: The outcome measures will include the indices of metabolic features as well as a 10-year risk for ischemic cardiovascular disease. Data analysis: The changes and %change of the metabolic features at 6- and 12-month will be compared among the two groups. Expected results: Whole soy diet substitution of high saturated fat and cholesterol rich animal products will notably decrease the risk of MetS.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Metabolic Syndrome

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    208 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Whole soy group
    Arm Type
    Experimental
    Arm Description
    Whole soy replacement diet: to incorporate 4 servings of whole soy foods (equivalent to 25g soy protein) into their daily diet and reduce high saturated fat and cholesterol rich animal foods.
    Arm Title
    Control group
    Arm Type
    Placebo Comparator
    Arm Description
    Usual diet: to receive a conventional lifestyle education on MetS.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Whole soy replacement diet
    Intervention Description
    Participants who are allocated to Whole soy group will receive a 30~40 min counseling session by an experienced nutritionist on: 1) conventional lifestyle education on metabolic syndrome (MetS); 2) The benefits of whole soy diet; 2) Practical techniques to incorporate of 4 servings of whole soy foods (equivalent to 25g soy protein) into their daily diet and reduce high saturated fat and cholesterol rich animal foods based on their prior 7-day dietary record during run-in; (3) Participants will also receive a pamphlet and an 30 min DVD which will provide practical cooking recipes with both illustration and demonstration on how to prepare whole soy foods/diet in an easy and fun way to replace fatty animal meat and dairy products
    Intervention Type
    Behavioral
    Intervention Name(s)
    usual diet
    Intervention Description
    Participants who are assigned to the usual diet group (control group) will receive a 5~10 min conventional lifestyle education on MetS by a research staff in which the general recommendation for macronutrient composition of the control diet will be 50-60% of energy as carbohydrate, 15-20% of energy as protein, and <30% of energy as total fat.
    Primary Outcome Measure Information:
    Title
    Changes of metabolic components of MetS (body weight, waist circumference, blood pressure, serum lipids and fasting glucose).
    Time Frame
    Will be measured at baseline, 6-month and 12-month after intervention.
    Secondary Outcome Measure Information:
    Title
    Changes of 10-year risk for ischemic cardiovascular disease (ICVD)
    Time Frame
    Will be assessed at baseline and 12-month after intervention.

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    45 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Postmenopausal women aged 45~70y within 15 years after menopause; Participants who meet 2 or more of the following items: waist circumference WC ≥80 cm; triglyceride concentration ≥1.7 mmol/l; HDL-c <50 mg/dl (1.29 mmol/l); SBP/DBP ≥130/85 mm Hg; fasting glucose ≥5.6 mmol/l. Exclusion Criteria: On use of medications known to affect body weight, lipids and glucose within past 3-month; Medical history or presence of severe systemic or endocrine diseases; Present or history of breast, endometrial or ovarian cancer; Abnormal uterine bleeding after menopause; On prescribed or vegetarian diet; Known soy allergy.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Zhao-min Liu, PhD
    Phone
    2252-8790
    Email
    liuzhaomin@cuhk.edu.hk

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    27678545
    Citation
    Liu ZM, Ho S, Hao YT, Chen YM, Woo J, Wong SY, He Q, Xie YJ, Tse LA, Chen B, Su XF, Lao XQ, Wong C, Chan R, Ling WH. Randomised controlled trial of effect of whole soy replacement diet on features of metabolic syndrome in postmenopausal women: study protocol. BMJ Open. 2016 Sep 27;6(9):e012741. doi: 10.1136/bmjopen-2016-012741.
    Results Reference
    derived

    Learn more about this trial

    Whole Soy Replacement Diet on Metabolic Features

    We'll reach out to this number within 24 hrs